Skip to main content
Premium Trial:

Request an Annual Quote

Pharmacia Turns to Genaissance for Pharmacogenomics

NEW YORK, Dec. 17-Genaissance will supply pharmacogenomics services for Pharmacia, the company said today.


Through this agreement, Genaissance will use its HAP technology to probe the genetics of drug response for compounds in clinical trials at Pharmacia.


Genaissance already has pharmacogenomic partnerships with AstraZeneca, Johnson & Johnson and Pfizer.


Financial details of the relationship were not disclosed, although Genaissance says that partnerships based on its HAP technology generally swap haplotype data access and services for a package that includes licensing fees, service fees, milestone payments and royalties.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.